Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets HM Zegallai, GM Hatch Molecular and cellular biochemistry 476, 1605-1629, 2021 | 42 | 2021 |
Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts EM Mejia, H Zegallai, ED Bouchard, V Banerji, A Ravandi, GM Hatch Journal of Biological Chemistry 293 (20), 7564-7577, 2018 | 33 | 2018 |
Tafazzin deficiency impairs mitochondrial metabolism and function of lipopolysaccharide activated B lymphocytes in mice HM Zegallai, E Abu‐El‐Rub, LK Cole, J Field, EM Mejia, JW Gordon, ... The FASEB Journal 35 (12), e22023, 2021 | 12 | 2021 |
Tafazzin deficiency in mouse mesenchymal stem cells promote reprogramming of activated B lymphocytes toward immunosuppressive phenotypes HM Zegallai, E Abu‐El‐Rub, F Olayinka‐Adefemi, LK Cole, GC Sparagna, ... The FASEB Journal 36 (8), e22443, 2022 | 5 | 2022 |
Mesenchymal stem cells and COVID-19: What they do and what they can do E Abu-El-Rub, RR Khasawneh, F Almahasneh, Z Altaany, N Bataineh, ... World journal of stem cells 13 (9), 1318, 2021 | 5 | 2021 |
Addressing the impact of high glucose microenvironment on the immunosuppressive characteristics of human mesenchymal stem cells RR Khasawneh, E Abu‐El‐Rub, FA Almahasneh, A Alzu'bi, HM Zegallai, ... IUBMB life 76 (5), 286-295, 2024 | 4 | 2024 |
Tafazzin regulates the function of lipopolysaccharide activated B lymphocytes in mice HM Zegallai, E Abu-El-Rub, LK Cole, J Field, EM Mejia, JW Gordon, ... bioRxiv, 2021.05. 17.444507, 2021 | 2 | 2021 |
The Molecular and Functional Changes of Neural Stem Cells in Alzheimer’s Disease: Can They be Reinvigorated to Conduct Neurogenesis E Abu-El-Rub, RR Khasawneh, FA Almahasneh, BM Aloud, HM Zegallai Current Stem Cell Research & Therapy 18 (5), 580-594, 2023 | 1 | 2023 |
Tafazzin deficiency attenuates anti-cluster of differentiation 40 and interleukin-4 activation of mouse B lymphocytes HM Zegallai, E Abu-El-Rub, EM Mejia, GC Sparagna, LK Cole, ... Cell and Tissue Research 390 (3), 429-439, 2022 | 1 | 2022 |
Impaired surface marker expression in stimulated Epstein-Barr virus transformed lymphoblasts from Barth Syndrome patients HM Zegallai, GM Hatch Scientific Reports 12 (1), 6195, 2022 | 1 | 2022 |
Mesenchymal stem cells derived secretome as an innovative cell-free therapeutic approach E Abu-El-Rub, RR Khasawneh, FA Almahasneh, HM Zegallai Biocell 46 (4), 907, 2022 | 1 | 2022 |
Reduced protein kinase C delta association with a higher molecular weight complex in mitochondria of Barth Syndrome lymphoblasts EM Mejia, HM Zegallai, GC Sparagna, GM Hatch bioRxiv, 2021.07. 21.453087, 2021 | 1 | 2021 |
Reduction in mRNA Expression of the Neutrophil Chemoattract Factor CXCL1 in Pseudomonas aeruginosa Treated Barth Syndrome B Lymphoblasts HM Zegallai, K Duan, GM Hatch Biology 12 (5), 730, 2023 | | 2023 |
Tafazzin knockdown in murine mesenchymal stem cells enhances the tafazzin knockdown mediated elevation in interleukin-10 secretion from murine B lymphocytes HM Zegallai, E Abu-El-Rub, GM Hatch bioRxiv, 2023.03. 01.530640, 2023 | | 2023 |
The impact of Tafazzin deficiency on the functional and immunological characteristics of B lymphocytes H Zegallai | | 2022 |
Tafazzin deficiency in mouse mesenchymal stem cells potentiates their immunosuppression and impairs activated B lymphocyte immune function HM Zegallai, E Abu-El-Rub, F Olayinka-Adefemi, LK Cole, GC Sparagna, ... bioRxiv, 2021.09. 07.459330, 2021 | | 2021 |
WJSC E Abu-El-Rub, RR Khasawneh, F Almahasneh, Z Altaany, N Bataineh, ... | | 2021 |
WJSC AN Sant'Ana, AB Araújo, FDC Gonçalves, AH Paz, A Goutas, V Trachana, ... | | |